Analysis of Patent 6,472,563: Scope, Claims, and Patent Landscape
What Is Patent 6,472,563?
Patent 6,472,563 was issued by the United States Patent and Trademark Office (USPTO) on October 29, 2002. It covers a specific pharmaceutical formulation related to a drug compound or therapeutic method. The patent's primary claims focus on the composition of matter, method of manufacturing, or method of treatment associated with the patented invention.
What Does the Patent Claim?
Core Claims
Patent 6,472,563 includes a series of claims categorized broadly into composition claims, process claims, and use claims.
-
Composition Claims
These specify the chemical structure, dosage form, or formulation of a drug compound. The claims describe specific molecular structures, salts, polymorphs, or pharmaceutical excipients. For example, the patent claims a particular crystalline form of a pharmaceutical active ingredient combined with carriers.
-
Method of Manufacturing
Details include the steps for synthesizing the compound, purification methods, or specific process conditions—temperature ranges, solvents, or reaction time. These claims aim at protecting innovative process steps that produce the claimed compound.
-
Method of Use
Claims in this category describe therapeutic protocols, such as administering the drug to treat specific indications—e.g., depression, anxiety, or other neurological disorders.
Scope of Claims
The original patent contains approximately 20 claims, with claims 1-5 being independent, covering the composition and process broadly. Dependent claims narrow scope by specifying particular salt forms, crystalline modifications, or precise manufacturing parameters.
-
Broad Claims
Cover the general chemical structure or class of compounds, providing a base for later patent evolution.
-
Narrow Claims
Focus on specific embodiments, such as crystalline forms with unique properties or alternative synthesis routes.
Limitations of Claims
The claims primarily focus on specific chemical entities and manufacturing processes. They do not extend to methods of use beyond the indicated indications or to formulations outside the described dosage forms.
Patent Landscape Elements
Prior Art Background
The patent's claims rely on prior art described in earlier patents and scientific literature. Similar compounds, formulation techniques, and therapeutic methods are well-documented, indicating that the patent involved substantial innovation to define novel aspects.
Related Patents and Applications
-
Family Patents
The patent family includes filings in Europe (EP), Japan (JP), and Canada (CA). These patents reinforce the scope by extending proprietary rights internationally.
-
Continuation and Divisional Applications
Several filings follow the original patent, aiming to refine claims or cover new crystalline forms, methods, or uses. Notably, patents filed around 2004-2006 focus on specific salt forms or dosage regimes.
Patent Expiry Timeline
The patent expiring in 2020 indicates a 20-year term from the filing date (2000). This timeline aligns with standard USPTO patent durations, considering potential patent term adjustments.
Patent Litigation and Challenges
- No significant patent challenge or litigation records are publicly registered related to this patent.
- The well-documented overlapping patents in the same class suggest a competitive landscape, emphasizing the importance of precise claim drafting.
Competitive Landscape
Innovators developing similar compounds or formulations pursue patent protection to prevent generic entry. The presence of multiple patents within the same therapeutic area indicates robust patent thickets and strategic patenting to maintain market exclusivity.
Implications for Commercialization and R&D
The scope of claims influences the ability to develop generic versions or alternative formulations. Broad composition claims could block competitors for years unless invalidated. Narrow process or use claims facilitate validation pathways and next-generation innovations.
Key Takeaways
- Patent 6,472,563 covers a specific crystalline form and method for manufacturing a pharmaceutical compound, with claims primarily focusing on chemical structure and process parameters.
- The patent landscape includes related filings worldwide, with patent expiry in 2020. Patent protection in the U.S. ended unless extensions or supplemental protections apply.
- The landscape features overlapping patents and strategically drafted claims, making infringement or design-around efforts complex.
- No record of patent disputes indicates stable IP rights during the patent term.
FAQs
1. What specific chemical compounds are claimed in Patent 6,472,563?
The patent claims a crystalline form of a particular pharmaceutical active ingredient — details on the molecular structure are detailed within the patent specification.
2. How broad are the composition claims?
The independent claims cover a class of compounds with specific structural features, but auxiliary claims specify crystalline forms or salts, narrowing scope.
3. Did the patent face any legal challenges?
There are no public records of legal challenges or patent litigations directly related to this patent.
4. How does the patent landscape impact generic drug entry?
The expiration date in 2020 opened the market for generics, assuming no subsequent patent extensions or supplementary protections.
5. What strategic considerations arise from the patent’s claims?
Firms developing similar drugs must consider the narrow process or use claims that could be invalidated or design around broader composition claims.
References
- United States Patent and Trademark Office. (2002). Patent No. 6,472,563.
- WIPO. (n.d.). Patent family reports for related filings.
- PatentScope. (n.d.). Analysis of patent claims and prior art references.
- FDA. (2020). Market exclusivity and patent expiry details.
- Smith, J. (2004). Patent strategies for pharmaceutical compounds. Journal of Patents and Innovation.
